Cargando…
The Role of the SLC Transporters Protein in the Neurodegenerative Disorders
The solute carrier (SLC) superfamily is one of the major sub-groups of membrane proteins in mammalian cells. The solute carrier proteins include more than 400 different membrane-spanning solute carriers organized with 65 families in the human. In solute carrier family neurons, neurotransmitter is co...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236796/ https://www.ncbi.nlm.nih.gov/pubmed/32329299 http://dx.doi.org/10.9758/cpn.2020.18.2.174 |
_version_ | 1783536214032252928 |
---|---|
author | Aykac, Asli Sehirli, Ahmet Ozer |
author_facet | Aykac, Asli Sehirli, Ahmet Ozer |
author_sort | Aykac, Asli |
collection | PubMed |
description | The solute carrier (SLC) superfamily is one of the major sub-groups of membrane proteins in mammalian cells. The solute carrier proteins include more than 400 different membrane-spanning solute carriers organized with 65 families in the human. In solute carrier family neurons, neurotransmitter is considered to be a pharmacological target of neuropsychiatric drugs because of their important role in the recovery of neurotransmitters such as GABA, glutamate, serotonin, dopamine and noradrenaline and regulation of their concentration in synaptic regions. Therefore, solute carrier transporters play vital and different roles in neurodegenerative disorders. In this article, the role of solute carrier transporters in neurodegenerative disorders such as Alzheimer disease, amyotrophic lateral sclerosis, Huntington disease, Parkinson’s diseases, depression, post-traumatic stress disorder, dementia, schizophrenia, and Epilepsy reviewed and discussed to see how defects or absences in SLC transporter cause neurodegenerative disorders. In this review, we try to summarize what is known about solute carriers with respect to brain distribution and expression. The review summarizes current knowledge on the roles of solute carrier transporters in neurodegenerative disorders. |
format | Online Article Text |
id | pubmed-7236796 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Korean College of Neuropsychopharmacology |
record_format | MEDLINE/PubMed |
spelling | pubmed-72367962020-05-31 The Role of the SLC Transporters Protein in the Neurodegenerative Disorders Aykac, Asli Sehirli, Ahmet Ozer Clin Psychopharmacol Neurosci Review The solute carrier (SLC) superfamily is one of the major sub-groups of membrane proteins in mammalian cells. The solute carrier proteins include more than 400 different membrane-spanning solute carriers organized with 65 families in the human. In solute carrier family neurons, neurotransmitter is considered to be a pharmacological target of neuropsychiatric drugs because of their important role in the recovery of neurotransmitters such as GABA, glutamate, serotonin, dopamine and noradrenaline and regulation of their concentration in synaptic regions. Therefore, solute carrier transporters play vital and different roles in neurodegenerative disorders. In this article, the role of solute carrier transporters in neurodegenerative disorders such as Alzheimer disease, amyotrophic lateral sclerosis, Huntington disease, Parkinson’s diseases, depression, post-traumatic stress disorder, dementia, schizophrenia, and Epilepsy reviewed and discussed to see how defects or absences in SLC transporter cause neurodegenerative disorders. In this review, we try to summarize what is known about solute carriers with respect to brain distribution and expression. The review summarizes current knowledge on the roles of solute carrier transporters in neurodegenerative disorders. Korean College of Neuropsychopharmacology 2020-05-31 2020-05-31 /pmc/articles/PMC7236796/ /pubmed/32329299 http://dx.doi.org/10.9758/cpn.2020.18.2.174 Text en Copyright © 2020, Korean College of Neuropsychopharmacology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Aykac, Asli Sehirli, Ahmet Ozer The Role of the SLC Transporters Protein in the Neurodegenerative Disorders |
title | The Role of the SLC Transporters Protein in the Neurodegenerative Disorders |
title_full | The Role of the SLC Transporters Protein in the Neurodegenerative Disorders |
title_fullStr | The Role of the SLC Transporters Protein in the Neurodegenerative Disorders |
title_full_unstemmed | The Role of the SLC Transporters Protein in the Neurodegenerative Disorders |
title_short | The Role of the SLC Transporters Protein in the Neurodegenerative Disorders |
title_sort | role of the slc transporters protein in the neurodegenerative disorders |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236796/ https://www.ncbi.nlm.nih.gov/pubmed/32329299 http://dx.doi.org/10.9758/cpn.2020.18.2.174 |
work_keys_str_mv | AT aykacasli theroleoftheslctransportersproteinintheneurodegenerativedisorders AT sehirliahmetozer theroleoftheslctransportersproteinintheneurodegenerativedisorders AT aykacasli roleoftheslctransportersproteinintheneurodegenerativedisorders AT sehirliahmetozer roleoftheslctransportersproteinintheneurodegenerativedisorders |